AlphaYouVF
Congress trade
Rep. Virginia Foxx (R-NC) bought $1K-$15K of GSK stock
Virginia Foxx, U.S. Representative (R-NC), disclosed a purchase of GSK stock worth $1K-$15K in a STOCK Act filing on Mar 7, 2022.
The trade happened on Feb 22, 2022, 13 days before it was made public.
GSK has moved -11.9% since the trade date, from $53.36 to $47.03 (Oct 2, 2026 close).
- Traded
- Feb 22, 2022
- Disclosed
- Mar 7, 2022
- Filing delay
- 13 days
- Price since
- -11.9%
- Source
- STOCK Act disclosure
Other trades in this disclosure (20)
- SellAM$50K-$100KMar 7, 2022
- BuyGIS$50K-$100KMar 7, 2022
- BuyKMI$50K-$100KMar 7, 2022
- SellSCHZ$50K-$100KMar 7, 2022
- BuyADM$15K-$50KMar 7, 2022
- BuyAEG$15K-$50KMar 7, 2022
- BuyFLO$15K-$50KMar 7, 2022
- BuyFLO$15K-$50KMar 7, 2022
- BuyMFC$15K-$50KMar 7, 2022
- SellMSFT$15K-$50KMar 7, 2022
- BuyPPL$15K-$50KMar 7, 2022
- BuyPSXP$15K-$50KMar 7, 2022
- BuyPSXP$15K-$50KMar 7, 2022
- BuyTSN$15K-$50KMar 7, 2022
- BuyAM$1K-$15KMar 7, 2022
- BuyDISCA$1K-$15KMar 7, 2022
- BuyEPD$1K-$15KMar 7, 2022
- BuyOXBR$1K-$15KMar 7, 2022
- BuyPAA$1K-$15KMar 7, 2022
- BuyT$1K-$15KMar 7, 2022
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.